Loading
A phase 2 trial of sintilimab and tegafur, gimeracil and oteracil (S-1) in pancreatic cancer, run by Ruijin Hospital, not yet recruiting.
Safety and Efficacy of Multimodal Thermal Therapy (MTT) Combined With KRAS G12V mRNA Vaccine, S-1, and Sintilimab in Patients With Metastatic Pancreatic Cancer is a phase 2, interventional study registered as NCT07745790 by Ruijin Hospital, with a registry enrolment figure of 20 participants, started 2026-07-13 and due to reach its primary completion in 2029-07-31. Interventions recorded: Multimodal Thermal Therapy (MTT) System; KRAS G12V mRNA Vaccine; Sintilimab; S-1. Conditions listed: Pancreatic Ductal Adenocarcinoma; Liver Neoplasms; Lung Neoplasms. Primary outcome: Incidence and Severity of Adverse Events (CTCAE v6.0); Frequency of Dose Modifications and Treatment Discontinuations. Pancreatic eligibility wording from the registry: "* Patients with advanced pancreatic cancer or postoperative recurrent pancreatic cancer confirmed by histopathological or cytological examination". Sites: China. No results are recorded here; the registry entry is the source.
Shares Sintilimab, Pancreatic cancer trials open today (registry snapshot and UK sites), Metastatic pancreatic ductal adenocarcinoma, Immune checkpoint inhibitors and the tag pancreatic-deep-dive.
Shares Sintilimab, Pancreatic cancer trials open today (registry snapshot and UK sites), Metastatic pancreatic ductal adenocarcinoma, Cytotoxic chemotherapy and the tag pancreatic-deep-dive.
Shares Sintilimab, Pancreatic cancer trials open today (registry snapshot and UK sites), Metastatic pancreatic ductal adenocarcinoma, Immune checkpoint inhibitors and the tag pancreatic-deep-dive.
Shares Sintilimab, Pancreatic cancer trials open today (registry snapshot and UK sites), Cytotoxic chemotherapy, Immune checkpoint inhibitors and the tag pancreatic-deep-dive.
Shares Tegafur, gimeracil and oteracil (S-1), Pancreatic cancer trials open today (registry snapshot and UK sites), Metastatic pancreatic ductal adenocarcinoma, Cytotoxic chemotherapy and the tag pancreatic-deep-dive.
Shares Sintilimab, Pancreatic cancer trials open today (registry snapshot and UK sites), Cytotoxic chemotherapy, Immune checkpoint inhibitors and the tag pancreatic-deep-dive.
Shares Sintilimab, Pancreatic cancer trials open today (registry snapshot and UK sites), Cytotoxic chemotherapy, Immune checkpoint inhibitors and the tag pancreatic-deep-dive.
Shares Pancreatic cancer trials open today (registry snapshot and UK sites), Metastatic pancreatic ductal adenocarcinoma, Cytotoxic chemotherapy, Immune checkpoint inhibitors and the tag pancreatic-deep-dive.